Press release
Nonmelanoma Skin Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | AstraZeneca, Pfizer, Replimune, Ortho Dermatologics, Philogen S.p.A.
The Key Nonmelanoma Skin Cancer Companies in the market include - Genentech, Sanofi, Sirnaomics, AiViva BioPharma, Replimune, Ortho Dermatologics, Philogen S.p.A., AstraZeneca, Pfizer, and others.DelveInsight's "Nonmelanoma Skin Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Nonmelanoma Skin Cancer, historical and forecasted epidemiology as well as the Nonmelanoma Skin Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Nonmelanoma Skin Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Nonmelanoma Skin Cancer Market Forecast [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Nonmelanoma Skin Cancer Market Report:
*
The Nonmelanoma Skin Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In December 2025, AiViva Biopharma Inc., a clinical-stage biotech company, has received FDA clearance to administer AIV001 (axitinib) via intradermal injection into facial skin for the treatment of nonmelanoma skin cancer. AIV001, a pan-tyrosine kinase inhibitor in a proprietary sustained-release formulation, gained approval based on safety, efficacy, and systemic exposure data from 67 subjects previously treated for basal cell carcinoma (BCC) and scar management on non-facial skin.
*
In August 2024, SkinCure Oncology, a global leader in offering a comprehensive model for delivering Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the leading nonsurgical treatment for common skin cancers, has announced the publication of a new study highlighting the importance of conducting full dermal visualization (FDV) through high-resolution dermal ultrasound (HRDUS) before each treatment fraction for nonmelanoma skin cancer (NMSC) using Image-Guided SRT.
*
Basal cell carcinoma represents approximately 80% of all skin cancer cases and typically occurs in sun-exposed areas like the face and neck. Squamous cell carcinoma accounts for about 20% of the remaining skin cancer cases.
*
Skin cancer is the most typical cancer, according to Cedars-Sinai (n.d.). Skin cancer accounts for between 40 and 50 percent of all cancer cases detected each year
*
Goldenberg et al. (2016) conducted a retrospective cohort analysis using Truven Health MarketScan database insurance claims, enrolling patients 18 years of age or older with two or more BCC claims that were at least 30 days apart between October 2011 and September 2012. The age-adjusted prevalence rate for BCC patients was 342.64 per 100,000. The prevalence rates were higher in males than in females, higher in patients 65 years of age or older, and lowest in patients 18 to 24 years of age
*
STP705, AIV001, RP1, and other new treatments for non-melanoma skin cancer (NMSC) are available. The market will be driven by the approval of these therapies because it will give patients new and varied treatment options
*
Key Nonmelanoma Skin Cancer Companies: Genentech, Sanofi, Sirnaomics, AiViva BioPharma, Replimune, Ortho Dermatologics, Philogen S.p.A., AstraZeneca, Pfizer, and others
*
Key Nonmelanoma Skin Cancer Therapies: VISMODEGIB (erivedge), LIBTAYO (cemiplimab-rwlc), STP705, AIV001, RP1, Tretinoin 0.1%, L19IL2 +L19TNF, Iressa, sirolimus, and others
*
The Nonmelanoma Skin Cancer epidemiology based on gender analyzed that Men are two times more likely than women to develop basal cell carcinoma and three times more likely to develop squamous cell carcinoma than Women
*
The Nonmelanoma Skin Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Nonmelanoma Skin Cancer pipeline products will significantly revolutionize the Nonmelanoma Skin Cancer market dynamics.
Nonmelanoma Skin Cancer Overview
Skin tumours that don't start out as melanoma are referred to as non-melanoma skin cancer. These more typical types of skin cancer are distinguished from the less frequent melanoma, which spreads more quickly in the body, by the name "non-melanoma."
Get a Free sample for the Nonmelanoma Skin Cancer Market Report
https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market [https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Nonmelanoma Skin Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Nonmelanoma Skin Cancer Epidemiology Segmentation:
The Nonmelanoma Skin Cancer market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total prevalent cases of NMSC in the 7MM (Basal cell carcinoma, Squamous cell carcinoma
*
Total diagnosed prevalent cases of NMSC in the 7MM
*
Treatable cases of NMSC in the 7MM
*
Gender-specific diagnosed prevalent cases of NMSC in the 7MM
*
Region-specific diagnosed prevalent cases of NMSC in the 7MM
*
Age-specific diagnosed prevalent cases of NMSC in the 7MM
Download the report to understand which factors are driving Nonmelanoma Skin Cancer epidemiology trends @ Nonmelanoma Skin Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Nonmelanoma Skin Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Nonmelanoma Skin Cancer market or expected to get launched during the study period. The analysis covers Nonmelanoma Skin Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Nonmelanoma Skin Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Nonmelanoma Skin Cancer Therapies and Key Companies
*
VISMODEGIB (erivedge): Genentech
*
LIBTAYO (cemiplimab-rwlc): Sanofi
*
STP705: Sirnaomics
*
AIV001: AiViva BioPharma
*
RP1: Replimune
*
Tretinoin 0.1%: Ortho Dermatologics
*
L19IL2 +L19TNF: Philogen S.p.A.
*
Iressa: AstraZeneca
*
sirolimus: Pfizer
Discover more about therapies set to grab major Nonmelanoma Skin Cancer market share @ Nonmelanoma Skin Cancer Treatment Market [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Nonmelanoma Skin Cancer Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Nonmelanoma Skin Cancer Companies: Genentech, Sanofi, Sirnaomics, AiViva BioPharma, Replimune, Ortho Dermatologics, Philogen S.p.A., AstraZeneca, Pfizer, and others
*
Key Nonmelanoma Skin Cancer Therapies: VISMODEGIB (erivedge), LIBTAYO (cemiplimab-rwlc), STP705, AIV001, RP1, Tretinoin 0.1%, L19IL2 +L19TNF, Iressa, sirolimus, and others
*
Nonmelanoma Skin Cancer Therapeutic Assessment: Nonmelanoma Skin Cancer current marketed and Nonmelanoma Skin Cancer emerging therapies
*
Nonmelanoma Skin Cancer Market Dynamics: Nonmelanoma Skin Cancer market drivers and Nonmelanoma Skin Cancer market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Nonmelanoma Skin Cancer Unmet Needs, KOL's views, Analyst's views, Nonmelanoma Skin Cancer Market Access and Reimbursement
To know more about Nonmelanoma Skin Cancer companies working in the treatment market, visit @ Nonmelanoma Skin Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Nonmelanoma Skin Cancer Market Report Introduction
2. Executive Summary for Nonmelanoma Skin Cancer
3. SWOT analysis of Nonmelanoma Skin Cancer
4. Nonmelanoma Skin Cancer Patient Share (%) Overview at a Glance
5. Nonmelanoma Skin Cancer Market Overview at a Glance
6. Nonmelanoma Skin Cancer Disease Background and Overview
7. Nonmelanoma Skin Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Nonmelanoma Skin Cancer
9. Nonmelanoma Skin Cancer Current Treatment and Medical Practices
10. Nonmelanoma Skin Cancer Unmet Needs
11. Nonmelanoma Skin Cancer Emerging Therapies
12. Nonmelanoma Skin Cancer Market Outlook
13. Country-Wise Nonmelanoma Skin Cancer Market Analysis (2020-2034)
14. Nonmelanoma Skin Cancer Market Access and Reimbursement of Therapies
15. Nonmelanoma Skin Cancer Market Drivers
16. Nonmelanoma Skin Cancer Market Barriers
17. Nonmelanoma Skin Cancer Appendix
18. Nonmelanoma Skin Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nonmelanoma-skin-cancer-market-to-reach-new-heights-in-growth-by-2034-delveinsight-predicts-astrazeneca-pfizer-replimune-ortho-dermatologics-philogen-spa]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonmelanoma Skin Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | AstraZeneca, Pfizer, Replimune, Ortho Dermatologics, Philogen S.p.A. here
News-ID: 4128562 • Views: …
More Releases from ABNewswire

Parkinson's Disease Levodopa-Induced Dyskinesia Market: Epidemiology, Therapies, …
The Parkinson's Disease Levodopa-induced Dyskinesia Treatment Market Report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Parkinson's disease Levodopa-induced Dyskinesia market size from 2020 to 2034. The report also covers Parkinson's Disease Levodopa-induced Dyskinesia Treatment Market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's potential.
Emerging therapies like GOCOVRI, JM-010, and NLX-112 are anticipated to drive growth…

SSR Law Offices Expands Personalized Legal Services to Roseville and Chesterfiel …
Image: https://www.abnewswire.com/upload/2025/09/145941fd072173357ff31f80d29bb133.jpg
SSR Law Offices, a respected Metro Detroit law firm specializing in Estate Planning, Elder Law, and Probate, is pleased to extend its legal services to clients in Roseville and Chesterfield, Michigan. With a proven reputation for combining professionalism with a personal touch, the firm is committed to providing tailored legal solutions that bring peace of mind to individuals and families facing life's most important decisions.
The need for thoughtful legal…

PhilFlorist.com Revolutionizes Online Flower Delivery in the Philippines with Af …
MANILA, PHILIPPINES - As the Philippines floriculture market continues its robust growth trajectory with an anticipated CAGR of 5.8% through 2031, PhilFlorist.com emerges as a leading digital platform transforming how Filipinos send flowers to the Philippines [https://www.philflorist.com/] and celebrate life's special moments. The company's innovative approach to online flower delivery addresses the growing demand for convenient, affordable gifting solutions in the archipelago nation.
The Asia Pacific cut flower market, valued at…

Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmac …
DelveInsight's, "Prostate Cancer - Pipeline Insight, 2025," report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Prostate Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Prostate Cancer pipeline companies are Silenseed LTD, Lantheus, Pantarhei Oncology,…
More Releases for Skin
Pipa Skin Care Introduces Skin Saver: The Ultimate Face and Body Mist for Tweens …
[MIAMI, FL - March 2025] Pipa Skin Care, the science-backed and pediatrician-approved skincare brand designed specifically for tweens with clean and safe ingredients, is launching Skin Saver (MSRP $16.99), a revolutionary face and body mist that helps fight acne-causing bacteria, calm irritation, and restore skin balance-all with just three clean ingredients.
At the core of Skin Saver is hypochlorous acid (HOCl), a powerful, dermatologist-recommended ingredient naturally found in the human immune…
Skin Scanner and Skin Analyzer Are the Same Thing?
Skin analyzers [http://www.meicet.com/], also known as Skin Scanners [http://www.meicet.com/], play a vital role in the beauty industry. With the continuous advancement of technology and the increasing demand for personalized skin care from consumers, more and more beauty industries have applied skin analyzers. This device uses high-tech means such as optical imaging and data analysis to deeply analyze skin conditions, including skin type, water-oil balance, wrinkles, spots, etc., to provide customers…
Natural Skin Essence Skin Tag Remover - Affordable Skin Tag Remover!
Skin tags are small, benign growths that appear on the skin. While they are generally harmless, many people find them unsightly and choose to remove them. Natural Skin Essence Skin Tag Remover has emerged as a popular, non-invasive solution for removing skin tags without the need for expensive and painful procedures. This article will delve into everything you need to know about Natural Skin Essence Skin Tag Remover, including its…
Skin Solutions Skin Tag Remover - Remove Unwanted Skin Tags Painlessly!
Are you tired of unsightly skin tags? You're not alone. Skin tags, though harmless, can be an aesthetic concern for many. They often appear in inconvenient places and can affect your confidence. Fortunately, there's a solution: Skin Solutions Skin Tag Remover. In this article, we'll explore everything you need to know about this popular skin tag removal product.
● Product Name - Skin Solutions Skin Tag Remover
● Main Benefits - Skin…
Allura Skin Glow Skin Tag Remover Eliminate Bothersome Skin Growths!
Are you frustrated with having to conceal your scars and wrinkles under layers of clothing? Do these skin issues make you feel embarrassed and self-conscious? Worry no more, because Allura Skin Glow Skin Tag Remover is the solution you've been looking for! This powerful serum targets blemishes and marks on your skin, helping you achieve flawless, silky-smooth skin quickly. In this article, we'll provide you with all the essential information…
Skin Arcadia Skin Tag Remover Voted #1 Skin Tag Remover!
Skin tags can be an unpleasant and annoying skin problem. These little, soft developments of skin normally appear on the neck, underarms, under the breasts, or in skin folds. While safe, many individuals turn to removal methods to eliminate these bothersome skin tags. Skin Arcadia Skin Tag Remover provides an all-natural, at-home option for removing skin tags without pain or scarring.
𝐒𝐇𝐈𝐏𝐏𝐈𝐍𝐆 𝐅𝐄𝐄 𝐎𝐍𝐋𝐘!!
📣𝗦𝗮𝗹𝗲 𝗶𝘀 𝗟𝗶𝘃𝗲 𝗡𝗼𝘄 👉👉 https://atozsupplement.com/skin-arcadia-skin-tag-remover/
✅Enjoy Your Bottle!!
What…